The Alpha 1 Acid Glycoprotein (orosomucoid) test serves as a biomarker plasma protein aiding in identifying infections, cancers, injuries, and obesity. As a positive acute-phase protein synthesized by the liver, healthcare professionals utilize this test to diagnose conditions such as myocardial infarction and stroke, sepsis, diabetes, chronic inflammatory disorders, and malignancies.